HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kunihiro Yamagata Selected Research

Dyslipidemias (Dyslipidemia)

1/2021Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study.
9/2019Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.
3/2012Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kunihiro Yamagata Research Topics

Disease

28Proteinuria
02/2022 - 12/2007
25Chronic Renal Insufficiency
11/2021 - 01/2007
21Glomerulonephritis
01/2021 - 09/2002
20Chronic Kidney Failure (Chronic Renal Failure)
09/2022 - 03/2004
20Vasculitis (Vasculitides)
01/2021 - 07/2004
16Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2021 - 02/2010
12IGA Glomerulonephritis (IGA Nephropathy)
10/2021 - 07/2002
11Hypertension (High Blood Pressure)
01/2020 - 03/2011
8Infections
11/2020 - 05/2005
7Renal Insufficiency (Renal Failure)
01/2020 - 04/2005
6Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 06/2012
6Microscopic Polyangiitis
01/2021 - 12/2009
6Inflammation (Inflammations)
01/2021 - 12/2005
6Diabetic Nephropathies (Diabetic Nephropathy)
11/2018 - 12/2007
6Diabetes Mellitus
01/2018 - 11/2009
5Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 05/2012
5Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2022 - 07/2002
5Membranous Glomerulonephritis (Membranous Nephropathy)
10/2020 - 06/2002
4Kidney Diseases (Kidney Disease)
03/2022 - 11/2007
4Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2021 - 02/2010
4Septic Shock (Toxic Shock Syndrome)
08/2016 - 08/2008
3Immunoglobulin Light-chain Amyloidosis
07/2022 - 08/2010
3Wounds and Injuries (Trauma)
02/2022 - 12/2016
3Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 08/2004
3Hematuria
10/2021 - 08/2010
3Body Weight (Weight, Body)
10/2021 - 11/2014
3Anemia
05/2021 - 05/2012
3Dyslipidemias (Dyslipidemia)
01/2021 - 03/2012
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 01/2019
3Constipation
02/2020 - 04/2017
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2020 - 08/2016
3Amyloidosis
11/2018 - 02/2013
3Sepsis (Septicemia)
08/2016 - 08/2011
3Obesity
01/2015 - 03/2012
3Hyperglycemia
11/2014 - 12/2007
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2022 - 01/2022
2Type 2 Diabetes Mellitus (MODY)
11/2021 - 05/2012
2Disease Progression
04/2021 - 12/2019
2Heart Failure
11/2020 - 12/2018
2Autosomal Dominant Polycystic Kidney (ADPKD)
01/2020 - 05/2016
2Coronary Disease (Coronary Heart Disease)
01/2019 - 08/2016
2Secondary Hyperparathyroidism
12/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

28Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021 - 07/2004
15CreatinineIBA
09/2022 - 11/2007
13Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2013
10Immunoglobulin A (IgA)IBA
07/2022 - 09/2002
9Peroxidase (Myeloperoxidase)IBA
10/2020 - 07/2004
8Antihypertensive Agents (Antihypertensives)IBA
01/2020 - 02/2012
7Glucose (Dextrose)FDA LinkGeneric
11/2021 - 02/2009
6Pharmaceutical PreparationsIBA
11/2021 - 12/2016
6Triglycerides (Triacylglycerol)IBA
11/2017 - 02/2014
6EnzymesIBA
08/2016 - 08/2008
6AntigensIBA
02/2010 - 07/2004
5SteroidsIBA
01/2022 - 01/2018
5Hemoglobins (Hemoglobin)IBA
05/2021 - 05/2012
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 07/2004
5Polymyxin B (Aerosporin)FDA LinkGeneric
08/2016 - 08/2008
5Antigen-Antibody Complex (Immune Complex)IBA
01/2014 - 07/2004
5Monoclonal AntibodiesIBA
05/2012 - 09/2002
4Immunoglobulin G (IgG)IBA
07/2022 - 06/2002
4Polysaccharides (Glycans)IBA
07/2022 - 08/2010
4Mitochondrial DNA (mtDNA)IBA
02/2022 - 07/2002
4Serum AlbuminIBA
01/2022 - 03/2011
4oxidized low density lipoproteinIBA
01/2021 - 10/2007
4Uric Acid (Urate)IBA
01/2020 - 12/2014
4Angiopoietin-1IBA
08/2016 - 12/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 08/2008
3Transcription Factors (Transcription Factor)IBA
03/2022 - 01/2020
3HematinicsIBA
05/2021 - 05/2012
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 07/2004
3Prednisolone (Predate)FDA LinkGeneric
01/2021 - 12/2009
3AlbuminsIBA
01/2019 - 05/2012
3antiglomerular basement membrane antibodyIBA
09/2017 - 10/2008
3HDL CholesterolIBA
08/2016 - 03/2014
3AngiopoietinsIBA
08/2016 - 12/2009
3Immunosuppressive Agents (Immunosuppressants)IBA
12/2009 - 12/2005
2Calcineurin InhibitorsIBA
01/2022 - 05/2021
2Cystatin CIBA
10/2021 - 06/2018
2AntibodiesIBA
04/2021 - 01/2007
2LipidsIBA
01/2021 - 10/2012
2C-Reactive ProteinIBA
01/2021 - 01/2014
2Biological ProductsIBA
11/2020 - 01/2018
2Phosphates (Orthophosphate)IBA
02/2020 - 05/2012
2ElectrolytesIBA
01/2020 - 11/2009
2MafB Transcription FactorIBA
01/2020 - 01/2018
2LDL CholesterolIBA
09/2019 - 08/2016
2LaxativesIBA
01/2019 - 04/2017

Therapy/Procedure

26Therapeutics
09/2019 - 07/2004
8Renal Dialysis (Hemodialysis)
12/2018 - 10/2005
6Remission Induction
07/2022 - 06/2012
6Hemoperfusion
08/2016 - 08/2008
5Renal Replacement Therapy (Therapies, Renal Replacement)
02/2022 - 03/2004
3Transplantation
01/2020 - 01/2006
3Peritoneal Dialysis
11/2018 - 12/2007
3Blood Component Removal (Apheresis)
01/2015 - 12/2005
2Activities of Daily Living (ADL)
07/2022 - 07/2018
2Plasma Exchange
06/2019 - 01/2019
2Tonsillectomy
03/2019 - 08/2016
2Aftercare (After-Treatment)
01/2019 - 05/2016
2Surgical Amputation (Amputations)
12/2018 - 11/2010